Montana’s plan to become an experimental medical hub just pushed forward
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing - sometimes in as few as 10 healthy people - can pay $12,500 to apply to a newly established review board for approval. Once its treatment is rubber-stamped, the company can set the price of the drug and sell it via experimental treatment clinics, the first of which is likely to be up and running around the end of this
The tech section covers stories about technology making life better, not just more profitable. Open-source tools reaching new audiences, accessibility breakthroughs, AI applications in healthcare and education, infrastructure improvements that quietly make cities work better. Product launches and funding rounds are excluded unless they deliver tangible public benefit.
A map showing the distribution of isotopes in Amazonian tree wood can help identify illegally harvested timber. By analy…
Information and communication technologies (ICTs) driven by artificial intelligence (AI) are generating data at an unpre…
The performance of many next-generation devices depends on controlling how energy flows at extremely small scales. In th…
Chemists Defy Decades-Old Rules With “Free Electron” Breakthrough SciTechDaily